Universitat de València’s researcher Nadezda Apostolova has been awarded the prize ‘Young Investigators Awards 2012’ given by the Federation of European Pharmacological Societies (EPHAR). This international prize awards the best three European pharmacists under 35 having a brilliant career in research. Nadezda Apostolova is employed at UV thanks to Juan de la Cierva programme and she researches and teaches at Facultat de Medicina’s Departament de Farmacologia.
Nadezda Apostolova has devoted her career to the study of the cell mechanisms involved in the side effects adscribed to Efavirenz, one of the most used antiretroviral drugs for AIDS treatment. She has been a pioneer in the description of a new mechanism of toxicity.
Nadezda Apostolova got a degree in biological sciences, especializing in biochemistry, in 2001 at a public university in Macedonia. She won the extraordinary mention for having the best average mark of the faculty in the last twenty years.
Later, she studied in a doctorate programme and finished her doctoral thesis at Universitat de València thanks to a lecturers training grant (FPU) of the Valencian Ministry of Education (2003-2008). Then, she began to work as a post-doctoral researcher for CIBERehd (CIBER for liver and digestive diseases, 2008-2011). In the last two years, Nadezda has won several post-doctoral contracts at public calls like the contract for the sub-programme Juan de la Cierva which links her to Departament de Farmacologia at Facultat de Medicina. Recenly, she has published many papers and co-supervised some doctoral theses.
In recognition of her work, she has just been awarded the ‘Young Investigators Awards 2010’ presented by the Federation of European Pharmacological Societies (EPHAR).
Last update: 28 de june de 2012 13:48.
News release
